Belimumab Market
This report contains market size and forecasts of Belimumab in global, including the following ma ... Read More
Biologicals for Systemic Lupus Erythematosus Market - Global Outlook and Forecast 2023-2028
1 Introduction to Research & Analysis Reports
1.1 Biologicals for Systemic Lupus Erythematosus Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologicals for Systemic Lupus Erythematosus Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologicals for Systemic Lupus Erythematosus Overall Market Size
2.1 Global Biologicals for Systemic Lupus Erythematosus Market Size: 2021 VS 2028
2.2 Global Biologicals for Systemic Lupus Erythematosus Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologicals for Systemic Lupus Erythematosus Players in Global Market
3.2 Top Global Biologicals for Systemic Lupus Erythematosus Companies Ranked by Revenue
3.3 Global Biologicals for Systemic Lupus Erythematosus Revenue by Companies
3.4 Top 3 and Top 5 Biologicals for Systemic Lupus Erythematosus Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biologicals for Systemic Lupus Erythematosus Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologicals for Systemic Lupus Erythematosus Players in Global Market
3.6.1 List of Global Tier 1 Biologicals for Systemic Lupus Erythematosus Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologicals for Systemic Lupus Erythematosus Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biologicals for Systemic Lupus Erythematosus Market Size Markets, 2021 & 2028
4.1.2 Rituximab
4.1.3 Belimumab
4.1.4 Anifrolumab
4.1.5 UBP-1213
4.1.6 Other
4.2 By Type - Global Biologicals for Systemic Lupus Erythematosus Revenue & Forecasts
4.2.1 By Type - Global Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2022
4.2.2 By Type - Global Biologicals for Systemic Lupus Erythematosus Revenue, 2023-2028
4.2.3 By Type - Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologicals for Systemic Lupus Erythematosus Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Other
5.2 By Application - Global Biologicals for Systemic Lupus Erythematosus Revenue & Forecasts
5.2.1 By Application - Global Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2022
5.2.2 By Application - Global Biologicals for Systemic Lupus Erythematosus Revenue, 2023-2028
5.2.3 By Application - Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biologicals for Systemic Lupus Erythematosus Market Size, 2021 & 2028
6.2 By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue & Forecasts
6.2.1 By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2022
6.2.2 By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue, 2023-2028
6.2.3 By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2028
6.3.2 US Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.3.3 Canada Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.3.4 Mexico Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2028
6.4.2 Germany Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4.3 France Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4.4 U.K. Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4.5 Italy Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4.6 Russia Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4.7 Nordic Countries Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.4.8 Benelux Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2028
6.5.2 China Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.5.3 Japan Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.5.4 South Korea Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.5.5 Southeast Asia Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.5.6 India Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2028
6.6.2 Brazil Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.6.3 Argentina Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2028
6.7.2 Turkey Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.7.3 Israel Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.7.4 Saudi Arabia Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
6.7.5 UAE Biologicals for Systemic Lupus Erythematosus Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologicals for Systemic Lupus Erythematosus Major Product Offerings
7.1.4 Roche Biologicals for Systemic Lupus Erythematosus Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Major Product Offerings
7.2.4 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Shanghai Junshi Biosciences
7.3.1 Shanghai Junshi Biosciences Corporate Summary
7.3.2 Shanghai Junshi Biosciences Business Overview
7.3.3 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Major Product Offerings
7.3.4 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Revenue in Global Market (2017-2022)
7.3.5 Shanghai Junshi Biosciences Key News
7.4 ACEA Biosciences
7.4.1 ACEA Biosciences Corporate Summary
7.4.2 ACEA Biosciences Business Overview
7.4.3 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Major Product Offerings
7.4.4 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Revenue in Global Market (2017-2022)
7.4.5 ACEA Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biologicals for Systemic Lupus Erythematosus Market Opportunities & Trends in Global Market
Table 2. Biologicals for Systemic Lupus Erythematosus Market Drivers in Global Market
Table 3. Biologicals for Systemic Lupus Erythematosus Market Restraints in Global Market
Table 4. Key Players of Biologicals for Systemic Lupus Erythematosus in Global Market
Table 5. Top Biologicals for Systemic Lupus Erythematosus Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biologicals for Systemic Lupus Erythematosus Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biologicals for Systemic Lupus Erythematosus Product Type
Table 9. List of Global Tier 1 Biologicals for Systemic Lupus Erythematosus Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologicals for Systemic Lupus Erythematosus Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biologicals for Systemic Lupus Erythematosus Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biologicals for Systemic Lupus Erythematosus Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biologicals for Systemic Lupus Erythematosus Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biologicals for Systemic Lupus Erythematosus Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Biologicals for Systemic Lupus Erythematosus Product Offerings
Table 32. Roche Biologicals for Systemic Lupus Erythematosus Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Product Offerings
Table 35. GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Revenue (US$, Mn), (2017-2022)
Table 36. Shanghai Junshi Biosciences Corporate Summary
Table 37. Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Product Offerings
Table 38. Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Revenue (US$, Mn), (2017-2022)
Table 39. ACEA Biosciences Corporate Summary
Table 40. ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Product Offerings
Table 41. ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biologicals for Systemic Lupus Erythematosus Segment by Type in 2021
Figure 2. Biologicals for Systemic Lupus Erythematosus Segment by Application in 2021
Figure 3. Global Biologicals for Systemic Lupus Erythematosus Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biologicals for Systemic Lupus Erythematosus Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biologicals for Systemic Lupus Erythematosus Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biologicals for Systemic Lupus Erythematosus Revenue in 2021
Figure 8. By Type - Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 12. US Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 16. Germany Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 17. France Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 24. China Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 28. India Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 30. Brazil Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biologicals for Systemic Lupus Erythematosus Revenue Market Share, 2017-2028
Figure 33. Turkey Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biologicals for Systemic Lupus Erythematosus Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Biologicals for Systemic Lupus Erythematosus Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
68